These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 2438723)
21. Effect of the selective PAF antagonist SM-10661 on an asthmatic model. 1. Effect on passive anaphylactic bronchoconstriction in guinea pigs. Uchida M; Imanishi N; Sugasawa T; Morooka S Lipids; 1991 Dec; 26(12):1301-4. PubMed ID: 1819720 [TBL] [Abstract][Full Text] [Related]
22. Failure of a combined anti-histamine and anti-leukotriene treatment to suppress passive anaphylaxis in the guinea-pig. Garcez Do Carmo L; Cordeiro R; Lagente V; Lefort J; Randon J; Vargaftig BB Int J Immunopharmacol; 1986; 8(8):985-95. PubMed ID: 2879805 [TBL] [Abstract][Full Text] [Related]
23. Action of platelet-activating factor (PAF) antagonists on the bronchopulmonary effects of PAF in the guinea-pig. Pons F; Touvay C; Lejeune V; Carré C; Vilain B; Broquet C; Mencia-Huerta JM; Braquet P J Lipid Mediat; 1989; 1(6):329-40. PubMed ID: 2519901 [TBL] [Abstract][Full Text] [Related]
24. The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene. Lefort J; Rotilio D; Vargaftig BB Br J Pharmacol; 1984 Jul; 82(3):565-75. PubMed ID: 6430375 [TBL] [Abstract][Full Text] [Related]
25. Gossypol: a potent inhibitor of PAF-acether- and leukotriene-induced contractions of guinea-pig lung parenchyma strips. Touvay C; Vilain B; Sirois P; Soufir M; Braquet P J Pharm Pharmacol; 1987 Jun; 39(6):454-8. PubMed ID: 2886603 [TBL] [Abstract][Full Text] [Related]
26. Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration. Modulation by prostacyclin, platelet depletion, and selective antagonists. Lellouch-Tubiana A; Lefort J; Simon MT; Pfister A; Vargaftig BB Am Rev Respir Dis; 1988 Apr; 137(4):948-54. PubMed ID: 3281530 [TBL] [Abstract][Full Text] [Related]
27. Active immunization induces lung hyperresponsiveness in the guinea pig. Pharmacologic modulation and triggering role of the booster injection. Pretolani M; Lefort J; Vargaftig BB Am Rev Respir Dis; 1988 Dec; 138(6):1572-8. PubMed ID: 3202509 [TBL] [Abstract][Full Text] [Related]
28. The booster injection of antigen during active sensitization of guinea-pig modifies the anti-anaphylactic activity of the PAF antagonist WEB 2086. Desquand S; Lefort J; Dumarey C; Vargaftig BB Br J Pharmacol; 1990 Jun; 100(2):217-22. PubMed ID: 2379029 [TBL] [Abstract][Full Text] [Related]
29. Proof of the involvement of platelet activating factor (paf-acether) in pulmonary complex immune systems using a specific paf-acether receptor antagonist: BN 52021. Touvay C; Vilain B; Taylor JE; Etienne A; Braquet P Prog Lipid Res; 1986; 25(1-4):277-88. PubMed ID: 2827186 [No Abstract] [Full Text] [Related]
30. Paf-induced release of spasmogens from guinea-pig lungs. Jancar S; Thériault P; Lauzière M; Braquet P; Sirois P Br J Pharmacol; 1989 Jan; 96(1):153-62. PubMed ID: 2538179 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of active anaphylaxis in mice and guinea pigs by the new hetrazepinoic PAF antagonist bepafant (WEB 2170). Heuer HO Eur J Pharmacol; 1991 Jun; 199(2):157-63. PubMed ID: 1954975 [TBL] [Abstract][Full Text] [Related]
32. Interference of BN 52021, a PAF-acether antagonist, with endotoxin-induced hypotension in the guinea-pig. Adnot S; Lefort J; Lagente V; Braquet P; Vargaftig BB Pharmacol Res Commun; 1986 Aug; 18 Suppl():197-200. PubMed ID: 3774845 [No Abstract] [Full Text] [Related]
33. The anaphylactic release of platelet-activating factor from perfused guinea-pig lungs. Fitzgerald MF; Moncada S; Parente L Br J Pharmacol; 1986 May; 88(1):149-53. PubMed ID: 3708213 [TBL] [Abstract][Full Text] [Related]
34. Effect of the hetrazepinoic platelet-activating factor antagonist Bepafant (WEB 2170) in models of active and passive anaphylaxis in mice and guinea pigs. Heuer HO Lipids; 1991 Dec; 26(12):1374-80. PubMed ID: 1819736 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of the vascular actions of IgG aggregates by BN 52021, a highly specific antagonist of paf-acether. Sánchez-Crespo M; Fernández-Gallardo S; Nieto ML; Baranès J; Braquet P Immunopharmacology; 1985 Oct; 10(2):69-75. PubMed ID: 3840779 [TBL] [Abstract][Full Text] [Related]
36. Effect of cyclosporin A and the platelet-activating factor (PAF) antagonist, BN 52021, on PAF- and antigen- induced bronchoconstriction in the guinea-pig. Touvay C; Vilain B; Lejeune V; Mencia-Huerta JM; Braquet P Biochem Biophys Res Commun; 1989 Aug; 163(1):118-23. PubMed ID: 2775253 [TBL] [Abstract][Full Text] [Related]
37. Effect of the PAF-antagonist WEB 2086 on anaphylactic lung reaction: comparison of inhalative and intravenous challenge. Heuer H; Casals-Stenzel J Agents Actions Suppl; 1988; 23():207-15. PubMed ID: 3262991 [TBL] [Abstract][Full Text] [Related]
38. Thrombus induction by endogenic paf-acether and its inhibition by Ginkgo Biloba extracts in the guinea pig. Bourgain RH; Maes L; Andries R; Braquet P Prostaglandins; 1986 Jul; 32(1):142-4. PubMed ID: 3763943 [TBL] [Abstract][Full Text] [Related]
39. Blockade by methylation inhibitors of the anaphylactic response of guinea-pig lung strips. Randon J; Lefort J; Vargaftig BB Br J Pharmacol; 1987 Nov; 92(3):683-91. PubMed ID: 2447992 [TBL] [Abstract][Full Text] [Related]
40. Limited interference of specific Paf antagonists with hyper-responsiveness to Paf itself of lungs from actively sensitized guinea-pigs. Pretolani M; Lefort J; Vargaftig BB Br J Pharmacol; 1989 Jun; 97(2):433-42. PubMed ID: 2474345 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]